We are live on ! Find out more
KRMD icon

KORU Medical Systems

65 hedge funds and large institutions have $38M invested in KORU Medical Systems in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more call options, than puts

Call options by funds: $12K | Put options by funds: $1K

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

10% more funds holding

Funds holding: 5965 (+6)

9.68% less ownership

Funds ownership: 41.03%31.35% (-9.7%)

14% less capital invested

Capital invested by funds: $44.3M → $38M (-$6.24M)

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
65
Holders Change
+6
Holders Change %
+10.17%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
22
Increased
11
Reduced
22
Closed
16
Calls
$12K
Puts
$1K
Net Calls
+$11K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
PD
51
Point72 (DIFC)
United Arab Emirates
$20.8K +$18K +7,864 New
SSG
52
Summit Securities Group
New York
$16K +$13.9K +6,058 New
CFM
53
Catalyst Funds Management
Australia
$13.5K +$11.7K +5,100 New
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$8.44K -$64.2K -28,059 -90%
Fidelity Investments
55
Fidelity Investments
Massachusetts
$7K +$1.27K +555 +27%
JP Morgan Chase
56
JP Morgan Chase
New York
$6.76K -$27.7K -12,090 -83%
Barclays
57
Barclays
United Kingdom
$6.19K -$51.9K -22,692 -91%
Macquarie Group
58
Macquarie Group
Australia
$4.45K +$3.84K +1,680 New
Citigroup
59
Citigroup
New York
$4.34K -$9.27K -4,052 -71%
SPIA
60
Steward Partners Investment Advisory
New York
$2.17K
Russell Investments Group
61
Russell Investments Group
United Kingdom
$1.25K +$1.08K +471 New
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$787 -$57.2K -25,000 -99%
Fifth Third Bancorp
63
Fifth Third Bancorp
Ohio
$239 +$206 +90 New
Nisa Investment Advisors
64
Nisa Investment Advisors
Missouri
$199 +$172 +75 New
EFMC
65
Empire Financial Management Company
New York
-$205K -87,000 Closed
Bank of New York Mellon
66
Bank of New York Mellon
New York
-$197K -83,458 Closed
N
67
Nuveen
North Carolina
-$147K -62,169 Closed
Renaissance Technologies
68
Renaissance Technologies
New York
-$116K -49,300 Closed
Invesco
69
Invesco
Georgia
-$93.8K -39,743 Closed
Deutsche Bank
70
Deutsche Bank
Germany
-$72.3K -30,626 Closed
VF
71
Virtu Financial
New York
-$63K -26,805 Closed
ARC
72
Advisor Resource Council
Texas
-$62.6K -25,500 Closed
AIG
73
American International Group
New York
-$40K -16,931 Closed
CCM
74
Carlson Capital Management
Minnesota
-$35.4K -15,000 Closed
Wells Fargo
75
Wells Fargo
California
-$24.4K -10,332 Closed

KRMD Hedge Fund Activity: Q2 2024 in Review

65 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in KORU Medical Systems (KRMD) for Q2 2024, worth a combined $38M — down 14% from $44.3M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KRMD positions and 16 closed out — a net gain of 6 holders — while 11 added to existing stakes and 22 trimmed.

The largest buyer was RBF Capital, opening a new position worth an estimated $1.83M. The largest seller was Archon Capital Management, cutting an estimated $6.64M.

  • 65 institutional investors held KORU Medical Systems (KRMD) as of Q2 2024, up from 59 in Q1 2024.
  • Funds reported $38M of KORU Medical Systems stock for Q2 2024, down 14% quarter-over-quarter.
  • 22 funds opened new KORU Medical Systems positions in Q2 2024 and 16 closed out, a net change of +6 holders.
  • The largest KORU Medical Systems buyer in Q2 2024 was RBF Capital, an estimated $1.83M added.
  • The largest KORU Medical Systems seller in Q2 2024 was Archon Capital Management, an estimated $6.64M sold.

Based on aggregated 13F filings for Q2 2024.